Molly O'Neill

Duke University Health System, Inc. engages in the provision of health care services. It offers cancer treatment, primary care, orthopedics, aesthetics, and fertility services. The company was founded in 1998 and is headquartered in Durham, NC.

WorldCare, Inc. develops and commercializes global healthcare services and solutions. The firm’s services include worldcare ACCESS, worldcare ALLY, worldcare TRAVELER, worldcareMD, worldcare CONCIERGE, worldcare expert medical resources, worldcare consulting and management. The company was founded in 1996 and is headquartered in Boston, MA.

Inova Health System provides health care services. It operates a network of hospitals, nursing homes, assisted living facilities, outpatient services and facilities, primary and specialty care physician practices, emergency and urgent care centers, home health care, mental health and blood donor services, wellness classes, and more. The company was founded in 1956 and is headquartered in Falls Church, VA.

Mass General Brigham, Inc. engages in the provision of patient care, research, teaching, and community services. It offers community and specialty hospitals, physician network, community health centers, and home care. The firm also sponsors research programs and community health outreach programs. The company was founded in 1994 and is headquartered in Boston, MA.

Aseko, Inc. develops network-based systems for glycemic management. The company was founded by Richard Lee Grounsell in March 2006 and is headquartered in Greenville, SC.

Ascension Health Care Network, Inc. is a catholic healthcare system. The firm provides an alternate funding source for the acquisition of catholic hospitals and other healthcare provider entities. The company was founded in 2011 and is headquartered in St. Louis, MO.

Part of Aseko, Inc., Glytec LLC is a healthcare provider company that specializes in improving the quality and cost of care for diabetes patients. The company, founded in 2006 by Robby Booth, is based in Waltham, MA, and has Edmond L. Furlong as its CEO since 2018. Glytec's FDA-cleared titration software and proprietary algorithms deliver personalized diabetes treatment recommendations across the continuum of care, from hospital to home. The company's eGlycemic Management System (eGMS) is an EHR-integrated cloud-based software solution that supports safe and effective glycemic management and insulin dosing. Glytec supports the transition from sliding scale to basal bolus insulin for standardization of insulin therapy across critical and non-critical care settings. The safety and efficacy of Glytec's solutions have been validated by several dozen studies published in medical journals and presented at scientific conferences.